Tinavi Medical Technologies Co.,Ltd. (SHA:688277)
China
· Delayed Price · Currency is CNY 12.60
+0.82 (6.96%)
Apr 30, 2025, 3:00 PM CST
SHA:688277 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Net Income | -160.48 | -156.39 | -110.58 | -79.93 | -54.47 | -30.96 | Upgrade
|
| Depreciation & Amortization | 38.77 | 38.77 | 44.51 | 35.31 | 8.25 | 7.74 | Upgrade
|
| Other Amortization | 5.95 | 5.95 | 5.65 | 6.3 | 8.62 | 7.54 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0 | -0 | 0.01 | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 4.55 | 4.55 | 0.74 | 0.42 | 1.92 | 0.2 | Upgrade
|
| Loss (Gain) From Sale of Investments | -56.22 | -56.22 | -0.1 | -3.57 | -7.71 | -6.87 | Upgrade
|
| Provision & Write-off of Bad Debts | 1.38 | 1.38 | -2.53 | 5.77 | 0.94 | - | Upgrade
|
| Other Operating Activities | 43.25 | 1.52 | 2.19 | 0.63 | 0.31 | -3.21 | Upgrade
|
| Change in Accounts Receivable | -86.69 | -86.69 | -2.44 | -25.02 | 26.85 | -6.26 | Upgrade
|
| Change in Inventory | 14.07 | 14.07 | -6.1 | -3.31 | -7.05 | -6.55 | Upgrade
|
| Change in Accounts Payable | 26.92 | 26.92 | 11.97 | 20.18 | -19.02 | 15.17 | Upgrade
|
| Change in Other Net Operating Assets | 25.13 | 25.13 | 1 | -12.55 | -1.98 | 50.6 | Upgrade
|
| Operating Cash Flow | -132.85 | -170.5 | -87.51 | -77.76 | -57.58 | 20.53 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | - | 56.12% | Upgrade
|
| Capital Expenditures | -51.44 | -221.03 | -59.59 | -238.66 | -132.17 | -20.17 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.03 | 0.01 | - | - | - | 0 | Upgrade
|
| Divestitures | 36 | 11.81 | - | - | - | 0.6 | Upgrade
|
| Investment in Securities | -39.08 | -49.51 | 66.48 | 127.73 | 25.65 | -134.69 | Upgrade
|
| Other Investing Activities | 0.38 | 0.55 | 2.73 | 12.2 | 6.76 | 7.18 | Upgrade
|
| Investing Cash Flow | -54.1 | -258.17 | 9.62 | -98.73 | -99.76 | -147.08 | Upgrade
|
| Long-Term Debt Issued | - | 201.17 | 25 | - | - | - | Upgrade
|
| Total Debt Issued | 66.04 | 201.17 | 25 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -27.94 | -22.94 | -28.91 | - | - | Upgrade
|
| Total Debt Repaid | -54.46 | -27.94 | -22.94 | -28.91 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | 11.59 | 173.23 | 2.06 | -28.91 | - | - | Upgrade
|
| Issuance of Common Stock | - | 363.7 | - | 7.02 | 468.12 | - | Upgrade
|
| Common Dividends Paid | -9.18 | -4.68 | -0.76 | - | - | - | Upgrade
|
| Other Financing Activities | 4.18 | -3.94 | - | 17.08 | 4.99 | -2.47 | Upgrade
|
| Financing Cash Flow | 6.59 | 528.3 | 1.3 | -4.8 | 473.11 | -2.47 | Upgrade
|
| Foreign Exchange Rate Adjustments | -1.53 | -0.17 | 0.65 | - | - | - | Upgrade
|
| Net Cash Flow | -181.9 | 99.47 | -75.93 | -181.29 | 315.77 | -129.03 | Upgrade
|
| Free Cash Flow | -184.29 | -391.53 | -147.1 | -316.42 | -189.75 | 0.36 | Upgrade
|
| Free Cash Flow Margin | -109.38% | -186.41% | -94.18% | -202.80% | -139.61% | 0.16% | Upgrade
|
| Free Cash Flow Per Share | -0.41 | -0.88 | -0.35 | -0.75 | -0.49 | 0.00 | Upgrade
|
| Cash Income Tax Paid | 4.68 | -4.3 | -4.85 | 2.71 | 7.03 | 10.81 | Upgrade
|
| Levered Free Cash Flow | -127.75 | -307.25 | -111.36 | -315.47 | -165.36 | -9.71 | Upgrade
|
| Unlevered Free Cash Flow | -122.93 | -303.23 | -108.89 | -313.38 | -165.36 | -9.71 | Upgrade
|
| Change in Net Working Capital | 18.69 | 19.05 | -8.84 | 15.94 | -12.8 | 12.94 | Upgrade
|
Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.